SL Science (SLBT) vs Solid Biosciences (SLDB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Solid Biosciences (SLDB) has outperformed SL Science (SLBT) over the past year, gaining 24.1% versus a loss of 85.4%. SL Science is the larger company by market cap ($841.1 million vs $713.0 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SLBT | SLDB |
|---|---|---|
| Share price | $1.50 | $6.65 |
| Market cap | $841.14M | $713.05M |
| 1-day change | -0.66% | -2.92% |
| YTD return | -85.68% | +21.45% |
| 1-year return | -85.42% | +24.09% |
| 5-year return | — | -79.70% |
| EPS (TTM) | $-0.01 | $-1.89 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.50 | $11.45 |
| 52-week low | $1.42 | $3.79 |
| Distance from 52-week high | -89.66% | -41.92% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +180.00% |
| Average volume | 80.93K | 1.09M |
| Shares outstanding | 560.76M | 107.23M |
| Employees | 14 | 121 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLDB has outperformed SLBT by 109.5 percentage points over the past year.
About SL Science
SLBT stock →SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company's products include SL bio's milk-derived exosome essence, SL bio's tangerine-derived extract, and the MilkExo concentrate series.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 14 employees
About Solid Biosciences
SLDB stock →Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 121 employees
SLBT vs SLDB FAQ
Which is bigger, SL Science or Solid Biosciences?
SL Science (SLBT) is larger, with a market capitalization of $841.14M compared with $713.05M for Solid Biosciences (SLDB).
Which stock has performed better over the past year, SLBT or SLDB?
SLDB returned +24.09% over the past 12 months, compared with -85.42% for SLBT (price return, excluding dividends). Past performance does not predict future results.
Are SL Science and Solid Biosciences in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.